ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
65,254.98
3.36%
S&P 500
5,736.83
0.25%
Dow Jones
42,152.60
0.57%
US Dollar vs Yen
144.6985
0.01%
Brent Oil
70.95
-3.06%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Cytek Biosciences Inc (CTKB)

  7. Cytek Biosciences Inc (CTKB) ニュース

CTKB

Cytek Biosciences (CTKB)

Cytek Biosciences Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CTKB
日付受信時刻ニュースソース見出しコード企業名
2024/09/1906 : 00GlobeNewswire Inc.Cytek® Biosciences Brings Full Spectrum Profiling™ (FSP™) Technology to the Forefront at Major Clinical Conferences in the U.S. and EuropeNASDAQ:CTKBCytek Biosciences Inc
2024/09/1707 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/09/1304 : 20GlobeNewswire Inc.Cytek Announces Resignation of Chief Operating Officer Chris WilliamsNASDAQ:CTKBCytek Biosciences Inc
2024/09/1219 : 04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
2024/08/2207 : 26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/08/2207 : 24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/08/2207 : 22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/08/2207 : 21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/08/2207 : 19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/08/2207 : 15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/08/2206 : 00GlobeNewswire Inc.Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing FacilityNASDAQ:CTKBCytek Biosciences Inc
2024/08/0905 : 05GlobeNewswire Inc.Cytek Biosciences to Participate in Upcoming Investor ConferencesNASDAQ:CTKBCytek Biosciences Inc
2024/08/0706 : 16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTKBCytek Biosciences Inc
2024/08/0705 : 16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
2024/08/0705 : 05GlobeNewswire Inc.Cytek Biosciences Reports Second Quarter 2024 Financial ResultsNASDAQ:CTKBCytek Biosciences Inc
2024/07/3106 : 00GlobeNewswire Inc.Cytek® Biosciences Automates Panel Design with New Intelligent AlgorithmNASDAQ:CTKBCytek Biosciences Inc
2024/07/3105 : 05GlobeNewswire Inc.Cytek Biosciences to Report Second Quarter 2024 Financial Results on August 6, 2024NASDAQ:CTKBCytek Biosciences Inc
2024/06/1205 : 02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTKBCytek Biosciences Inc
2024/06/0808 : 03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/06/0807 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/06/0621 : 00GlobeNewswire Inc.Cytek Biosciences Announces $50 Million Stock Repurchase ProgramNASDAQ:CTKBCytek Biosciences Inc
2024/06/0105 : 48Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:CTKBCytek Biosciences Inc
2024/05/3105 : 05GlobeNewswire Inc.Cytek Biosciences to participate at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:CTKBCytek Biosciences Inc
2024/05/2906 : 30GlobeNewswire Inc.1-Laser and 2-Laser 6-Color TBNK Reagents from Cytek® Biosciences Approved for Clinical Use in ChinaNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
2024/05/2307 : 28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTKBCytek Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:CTKB

最近閲覧した銘柄

AMEX
XLF
Financial Select Sector
PM
XAUUSD
Gold vs US Dollar
COIN
BTCUSD
Bitcoin
USI
USTECH100
US Tech 100
NYSE
XOM
Exxon Mobil
NASDAQ
MSFT
Microsoft
NYSE
BAC
Bank of America
COIN
DOGEUSD
Dogecoin
AMEX
XLE
Energy Select Sector SPDR
NYSE
VZ
Verizon Communications
COIN
ETHUSD
Ethereum
FX
USDGBP
US Dollar vs Sterling
NYSE
KO
Coca Cola
COIN
ADAUSD
Cardano
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有